Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Craniospinal Irradiation in Histone AlteRed Midline Glioma (CHARM) - A Phase II Open Label Prospective Study

NCT06720727 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT06720727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06720727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Craniospinal Irradiation in Histone AlteRed Midline Glioma (CHARM) - A Phase II Open Label Prospective Study
Lead sponsor
Tata Memorial Centre
Phase
Not applicable
Overall status
Recruiting
Start date
January 3, 2025
Completion date
November 8, 2028
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma